Mishra, N., Kumar, M., Singh, S., & Rani, K. (2023). Re-do cytoreductive surgery with hyperthermic intra-peritoneal chemotherapy (HIPEC): Risk factors and complications. Journal of Cancer Research & Therapeutics, 19, 921. https://doi.org/10.4103/jcrt.jcrt_354_22
Chicago Style (17th ed.) CitationMishra, Namita, Madhav Kumar, Soumya Singh, and Khushbu Rani. "Re-do Cytoreductive Surgery with Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Risk Factors and Complications." Journal of Cancer Research & Therapeutics 19 (2023): 921. https://doi.org/10.4103/jcrt.jcrt_354_22.
MLA (9th ed.) CitationMishra, Namita, et al. "Re-do Cytoreductive Surgery with Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Risk Factors and Complications." Journal of Cancer Research & Therapeutics, vol. 19, 2023, p. 921, https://doi.org/10.4103/jcrt.jcrt_354_22.